The number of animals used in scientific experiments will be reduced under new EU legislation agreed by the European Parliament …
Protalix BioTherapeutics has appointed Tzvi Palash to the newly-created position of chief operating officer. He will be responsible for overseeing …
Johnson & Johnson’s disagreement with Merck over rights to two arthritis drugs is set to come to a head in …
InVentiv Health is to acquire Star Terre Santé, a leading group of healthcare marketing and communications agencies based in Paris. …
Pharma execs are more confident about the sector’s outlook than they were at the start of the year. A survey …
The Greek government has released a list of over 4,000 drugs on which it will impose heavy price cuts. This …

Bristol-Myers Squibb is to acquire biopharma company ZymoGenetics for $885 million to add to its ‘string of pearls’of small biotech …
Judith Teall has been appointed director of patient recruitment at clinical trial technology company Exco InTouch. She has spent more …

How did you find your way into your most current role? I’ve been at Napp for four years now having …
Primary care trust managers should not have a legal right to transfer to similar roles in GP commissioning groups, according …
Pfizer has dropped its experimental brain cancer vaccine rindopepimut, handing back worldwide rights to Celldex Therapeutics from November. Rindopepimut targets …
Roche has signed a deal with Belgian biotech reMYND to develop new treatments for patients with Alzheimer’s and Parkinson’s disease. …
Merck & Co has postponed the planned closure of the former Organon facility in Oss, the Netherlands, after weeks of …
Sun Pharmaceuticals’ manufacturing operations have been found wanting by FDA for the second time in recent months, once again for …
A round-up of pharma manufacturing developments from Ranbaxy, SemBioSys, Halozyme, Aegis Protek, Alexion and Thomson/Rondaxe. Ranbaxy Laboratories of India has …
Transatlantic specialty company Eusa Pharma has appointed Stephen Stamp to its board as an independent non-executive director. Stephen has previously …
Russian active pharmaceutical ingredient manufacturer Pharmsynthez is planning a listing on the MICEX stock exchange to help it expand beyond …
Bayer is to launch a new formulation of its erectile dysfunction drug Levitra. The European Commission granted Levitra (verdenafil HCI) …

GlaxoSmithKline is under mounting pressure this week as calls intensify for its type II diabetes drug Avandia to be withdrawn …
The ABPI has blamed parallel trading by a minority of pharmacists as the root cause of the current medicines shortage …